Status:
COMPLETED
TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Consortium to Respond Effectively to the AIDS/Tuberculosis Epidemic
Communicable Disease Program, Brazil
Conditions:
Tuberculosis
HIV Infections
Eligibility:
All Genders
16+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine if implementing a policy of widespread INH (Isoniazid) prophylaxis therapy in HIV-infected patients with access to antiretroviral therapy reduces the incidenc...
Detailed Description
Tuberculosis remains a major public health problem in Brazil. Approximately 35% of HIV-infected adults in Rio de Janeiro are co-infected with latent TB. The Brazilian policies for the provision of tre...
Eligibility Criteria
Inclusion
- Attending 1 of 29 participating HIV clinics
- Confirmed HIV infection
- Age \> 15 years
Exclusion
- Current active TB disease
- TB infection within 2 years
- Hepatitis
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
17415 Patients enrolled
Trial Details
Trial ID
NCT00107887
Start Date
June 1 2005
End Date
December 1 2010
Last Update
June 15 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Rio De Janeiro Health Department Clinics
Rio de Janeiro, Rio de Janeiro, Brazil, 20211-110